JB Hi-Fi Limited

JBH

JB Hi-Fi Ltd. engages in the retail of home consumer products from stand-alone destination sites, shopping center locations, and online stores. The company is headquartered in Southbank, Victoria and currently employs 16,000 full-time employees. The company went IPO on 2003-10-23. The firm offers a range of brands with particular focus on consumer electronics, software (including music, games and movies), whitegoods and appliances. Its retail brands include JB Hi-Fi, The Good Guys and e&s. The firm's segments include JB Hi-Fi Australia, JB Hi-Fi New Zealand, The Good Guys and e&s. The JB Hi-Fi brand is a retailer of technology and consumer electronics with a position with a young tech-savvy demographic. The Good Guys brand is a retailer of home appliances and consumer electronics with a position with home-making families. The e&s brand is engaged in the kitchen, laundry and bathroom product segments. Its products include consumer electronics and technology products, telecommunications products and services, home appliances, and software (music, movies and games) and associated collectibles and merchandise. The company also provides information technology and consulting services.

Lion Rock Minerals Ltd

LRM

Lion Rock Minerals Ltd is a AU-based company operating in Metals & Mining industry. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2003-07-17. Lion Rock Minerals Limited, formerly Peak Minerals Limited, is an Australia-based exploration and development company. The Company’s projects include Minta Rutile, Kitongo and Lolo Uranium Projects, Green Rocks, and Yendon Kaolin-REEs. The Minta Rutile Project comprises 18 granted exploration permits, and three exploration permits under application, across 8,800 square kilometers (km2) in a critically under-explored area of known rutile mineralization in central Cameroon. The Kitongo and Lolo Uranium Projects span approximately 2,400 km2 and include six exploration permits. The Green Rocks Project is located approximately 35km to the southeast of Meekatharra and covers over 234 km2. The Yendon HPA Project focuses on copper and gold exploration.

Vanguard Diversified High Growth Index ETF

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Harvey Norman Holdings Limited

HVN

Harvey Norman Holdings Ltd. engages in the retail, franchise, property, and digital enterprise business. The company is headquartered in Sydney, New South Wales. The Company’s principal activities include franchisor; omnichannel retailing of furniture, bedding, computers, communications and consumer electrical products in New Zealand, Singapore, Malaysia, Slovenia, Ireland, Northern Ireland and Croatia; property investment; lessor of premises to Harvey Norman, Domayne and Joyce Mayne franchisees and other third parties; media placement; and provision of consumer finance and other commercial loans and advances. Its segments include Franchising Operations, New Zealand (retail), Singapore & Malaysia (retail), Slovenia & Croatia (retail), Ireland (retail), United Kingdom (retail), Other Non-Franchised Retail, Retail Property, Retail Property Under Construction, Property Developments for Resale, Equity Investments, and Other. Its brands sell products under various categories, including electrical goods, furniture, and others.

Telix Pharmaceuticals Limited

TLX

Telix Pharmaceuticals Limited.engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.